Management of Metastatic Breast Cancer, Including SABCS Updates |
0.75 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Management of Toxicities with Targeted Therapies for Breast Cancer |
0.25 |
03/15/2020 - 12:00am to 03/15/2021 - 12:00am |
Practical Application of Immuno-Oncology in Renal Cell Carcinoma |
1.75 |
03/17/2020 - 12:00am to 03/17/2021 - 12:00am |
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Lung Cancer |
1.00 |
03/18/2020 - 12:00am to 03/18/2021 - 12:00am |
Archived Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care - Multiple Myeloma |
0.75 |
03/18/2020 - 12:00am to 03/18/2021 - 12:00am |
BCOP Test - Current Therapy Options for Graft-Versus-Host Disease |
|
04/01/2020 - 2:00pm to 04/01/2021 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: Current Therapy Options for Graft-Versus-Host Disease |
1.00 |
04/07/2020 - 12:00am to 04/01/2021 - 12:00am |
NCCN Guidelines® Insights - Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020 |
1.00 |
04/10/2020 - 12:00am to 04/10/2021 - 12:00am |
Talking to Patients about Cancer Treatment, Risk Factors, and Treatment Cessation during the COVID-19 Pandemic |
1.00 |
04/20/2020 - 12:00am to 04/20/2021 - 12:00am |
BCOP Test - New Targets and Treatment Options for Acute Myeloid Leukemia |
|
04/28/2020 - 2:00pm to 04/28/2021 - 12:00am |
Recorded Presentation from the NCCN Pharmacy Updates: New Targets and Treatment Options for Acute Myeloid Leukemia |
1.00 |
04/30/2020 - 12:00am to 04/28/2021 - 12:00am |
Practical Use of Next Generation Sequencing in Metastatic Disease |
0.50 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
Treatment Considerations in Older Adult Oncology |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
Immune Checkpoint Inhibitor Toxicities |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |
The Role of Biosimilars in Cancer Treatment |
0.75 |
05/08/2020 - 12:00am to 03/01/2021 - 12:00am |